ImmuneID is a series a startup based in United States. 1 investor tracked.
ImmuneID is a startup founded in 2020 based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
ImmuneID is a biotechnology company that has developed a platform to identify and therapeutically target antibody interactions that drive immune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.